Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -8.69x is 30% above its 5-year average of -12.50x, near the high end of its 5-year range (-401.63x–69.66x).
227.04% below its 12-month average of 6.84x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 69.66x.
INTEREST COVERAGE RATIO
-8.69x
INTEREST COVERAGE RATIO AVG TTM
6.84x
INTEREST COVERAGE RATIO AVG 3Y
-12.58x
INTEREST COVERAGE RATIO AVG 5Y
-12.50x
INTEREST COVERAGE RATIO AVG 10Y
-188.70x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-227.04%
CURRENT VS 3Y AVG
+30.93%
CURRENT VS 5Y AVG
+30.49%
CURRENT VS 10Y AVG
+95.39%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.79x
median of 488 covered companies
CURRENT VS SECTOR MEDIAN
-50.09%
vs the sector median at left
MeiraGTx Holdings plc
Market Cap
$979.81M
Interest Coverage Ratio
-8.69x
TTM Avg
6.84x
3Y Avg
-12.58x
5Y Avg
-12.50x
Market Cap
$977.59M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$977.47M
Interest Coverage Ratio
2.28x
TTM Avg
2.28x
3Y Avg
3.01x
5Y Avg
2.79x
Market Cap
$990.27M
Interest Coverage Ratio
-28.96x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$968.36M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.00B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$949.44M
Interest Coverage Ratio
-200.81x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$948.56M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MeiraGTx Holdings plc (MGTX) | $979.81M | -8.69x | 6.84x | -12.58x | -12.50x |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $977.59M | N/A | N/A | N/A | N/A |
| Pacira BioSciences, Inc. (PCRX)vs › | $977.47M | 2.28x | 2.28x | 3.01x | 2.79x |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $990.27M | -28.96x | N/A | N/A | N/A |
| Aktis Oncology, Inc. (AKTS)vs › | $968.36M | N/A | N/A | N/A | N/A |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $1.00B | N/A | N/A | N/A | N/A |
| Savara Inc. (SVRA)vs › | $953.94M | N/A | N/A | N/A | N/A |
| Kura Oncology, Inc. (KURA)vs › | $949.44M | -200.81x | N/A | N/A | N/A |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $948.56M | N/A | N/A | N/A | N/A |
| MoonLake Immunotherapeutics (MLTX)vs › | $936.20M | -33.78x | N/A | N/A | N/A |
Interest Coverage
-8.7x
Debt/Equity
0.52
Current Ratio
3.76
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 69.66x |
| 2026-03-31 | -14.33x |
| 2025-12-31 | 8.67x |
| 2025-09-30 | -15.02x |
| 2025-06-30 | -14.76x |
| 2025-03-31 | -13.67x |
| 2024-12-31 | -9.23x |
| 2024-09-30 | -11.93x |
| 2024-06-30 | -14.11x |
| 2024-03-31 | -14.39x |
| 2023-12-31 | -12.69x |
| 2023-09-30 | -9.69x |
| 2023-06-30 | -8.58x |
| 2023-03-31 | -10.38x |
| 2022-12-31 | -14.18x |
| 2022-09-30 | -12.05x |
| 2022-06-30 | -289.73x |
| 2022-03-31 | -373.17x |
| 2021-12-31 | -68.27x |
| 2021-09-30 | -382.24x |
| 2021-06-30 | -401.63x |
| 2021-03-31 | -373.42x |
| 2020-12-31 | -366.61x |
| 2020-09-30 | -239.92x |
| 2020-06-30 | -740.93x |
| 2020-03-31 | -461.64x |
| 2019-12-31 | -268.13x |
| 2019-09-30 | -1174.91x |
| 2019-06-30 | -2245.32x |
| 2019-03-31 | -2161.14x |
| 2018-09-30 | -1550.09x |
| 2018-06-30 | -2592.58x |
| 2018-03-31 | -659.82x |
| 2017-09-30 | -120.47x |
| 2017-06-30 | -149.04x |
| 2017-03-31 | -857.97x |
